Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Yield stocks
Trend-Following Stocks
Growth stocks
Quality stocks
Momentum stocks
ESG stocks
Investment Themes
Biotechnology
Robotics
The Vegan Market
US Basketball
Strategic Metals
Boats
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
Water
The Cannabis Industry
The future of mobility
Sin stocks
Education
Strategic Metals
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
Our subscriptions
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
France
Euronext Paris
GENFIT
News
Summary
GNFT
FR0004163111
GENFIT
(GNFT)
Add to my list
Report
Real-time Euronext Paris -
11:36 2022-08-12 am EDT
4.460
EUR
-4.99%
08/11
European ADRs Move Lower in Thursday Trading
MT
08/10
European ADRs Climb Higher in Wednesday Trading
MT
08/01
European ADRs Move Higher in Monday Trading
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
European ADRs Move Slightly Higher in Wednesday Trading
06/29/2022 | 11:06am EDT
Send by mail :
Name :
First name :
From
*
:
To
*
:
(You can enter multiple email addresses separated by commas)
Message :
*
Required fields
© MT Newswires 2022
Stocks mentioned in the article
Change
Last
1st jan.
AKARI THERAPEUTICS, PLC
-0.99%
1.4851
-0.99%
ASTRAZENECA PLC
1.96%
10712
23.44%
BICYCLE THERAPEUTICS PLC
1.31%
26.25
-56.88%
CARNIVAL CORPORATION
1.71%
10.72
-46.72%
CELLECTIS S.A.
-0.28%
3.614
-51.42%
ENI SPA
0.35%
11.63
-4.83%
GENFIT
-4.99%
4.46
3.34%
GRIFOLS, S.A.
-0.61%
13.755
-18.49%
HSBC HOLDINGS PLC
0.29%
550.5
22.70%
LONDON BRENT OIL
-0.38%
97.14
27.42%
MEREO BIOPHARMA GROUP PLC
17.39%
1.35
-15.63%
MORPHOSYS AG
0.39%
23.15
-30.58%
NOVO NORDISK A/S
-2.67%
770
4.76%
PEARSON PLC
-0.52%
881.6
43.77%
SEQUANS COMMUNICATIONS S.A.
-1.45%
3.4
-28.27%
TELEFÓNICA, S.A.
-0.23%
4.273
10.93%
VERONA PHARMA PLC
15.17%
13.59
102.23%
WTI
-0.42%
91.181
24.73%
All news about GENFIT
08/11
European ADRs Move Lower in Thursday Trading
MT
08/10
European ADRs Climb Higher in Wednesday Trading
MT
08/01
European ADRs Move Higher in Monday Trading
MT
07/25
European ADRs Move Higher in Monday Trading
MT
07/15
European ADRs Move Higher in Friday Trading
MT
07/13
European ADRs Move Higher in Wednesday Trading
MT
07/12
European ADRs Move Lower in Tuesday Trading
MT
07/11
GENFIT, Half-Year Report of Liquidity Contract with Credit Industriel et Commercial
AQ
07/08
GENFIT
: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial - For..
PU
07/08
GENFIT
: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
GL
More news
Analyst Recommendations on GENFIT
04/11
SVB Leerink Adjusts Genfit's Price Target to $10 from $15, Keeps Outperform Rating
MT
2021
HC Wainwright Upgrades Genfit to Buy From Neutral; Price Target is $8
MT
2021
GENFIT
: HC Wainwright Trims Price Target on Genfit to $7 From $8, Keeps Neutral Rating
MT
More recommendations
Financials
EUR
USD
Sales 2022
15,0 M
15,4 M
15,4 M
Net income 2022
-46,4 M
-47,6 M
-47,6 M
Net cash 2022
56,2 M
57,7 M
57,7 M
P/E ratio 2022
-5,33x
Yield 2022
-
Capitalization
222 M
227 M
227 M
EV / Sales 2022
11,0x
EV / Sales 2023
4,01x
Nbr of Employees
122
Free-Float
78,7%
More Financials
Chart GENFIT
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Full-screen chart
Technical analysis trends GENFIT
Short Term
Mid-Term
Long Term
Trends
Bullish
Bullish
Neutral
Technical analysis
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
More Financials
Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4,46 €
Average target price
10,23 €
Spread / Average Target
129%
Consensus
EPS Revisions
Please enable JavaScript in your browser's settings to use dynamic charts.
More Estimates Revisions
Managers and Directors
Pascal Prigent
CEO & EVP-Marketing & Development
Thomas Baetz
Chief Financial Officer
Jean-François Mouney
Chairman
Dean W. Hum
Chief Scientific Officer
Carol L. Addy
Chief Medical Officer
More about the company
Sector and Competitors
1st jan.
Capi. (M$)
GENFIT
3.34%
227
MODERNA, INC.
-32.60%
66 966
IQVIA HOLDINGS INC.
-12.88%
45 846
LONZA GROUP AG
-25.13%
44 851
SEAGEN INC.
10.05%
31 380
ALNYLAM PHARMACEUTICALS, INC.
37.90%
28 068
More Results
Slave